Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor > Recombinant DNA-technology > DNA or RNA fragments; Modified forms thereof > Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00) > Recombinant DNA-technology > DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); > Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs